Zinnia B. Cuyotupa-Cosme
Research Subjects
Zinnia B. Cuyotupa-Cosme has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ariana Alejandra Alvarez-Rojas
Astrocyte, Neurosurgical Research Group, Boston, MA, USA
1 shared publication - Carlos Quispe-Vicuña
Grupo de Investigación Neurociencias, Metabolismo, Efectividad Clínica y Sanitaria (NEMECS) Universidad Científica del Sur Lima Peru
1 shared publication - Diana Carolina Salazar-Flores
Faculty of Medicine. Universidad Peruana Cayetano Heredia
1 shared publication - Fritz Fidel Váscones-Román
Faculty of Medicine, Universidad Peruana Cayetano Heredia, Lima, Peru; Harvard T.H. Chan School of Public Health, Harvard University, Boston, MA, United States of America; Váscones's Lab, Lima, Peru
1 shared publication - Karlos Acurio
Astrocyte, Neurosurgical Research Group, Boston, MA, USA
1 shared publication - Kevin Pacheco-Barrios
Neuromodulation Center and Center for Clinical Research Learning, Spaulding Rehabilitation Hospital and Massachusetts General Hospital, Harvard Medical School, Boston, MA 02138, USA
1 shared publication
Latest Publications
- 1 June 2026
- Published by Hospital Vozandes Quito - HVQ SA in Revista Medica Vozandes
- Vol. 36 (2) , 29
CLINICAL CHARACTERISTICS AND OUTCOMES OF LATIN AMERICAN PATIENTS WITH ACUTE ISCHEMIC STROKE AND LARGE VESSEL OCCLUSION: A SYSTEMATIC REVIEW AND EXPLORATORY META-ANALYSIS
Background Large vessel occlusion is a major cause of stroke-related disability and death and often requires access to specialized reperfusion strategies such as mechanical thrombectomy. However, published data from Latin America remain limited and methodologically heterogeneous. This study aimed to summarize the available evidence on the characteristics, management patterns, and clinical outcomes of Latin American cohorts of patients with acute ischemic stroke (AIS) and confirmed or treatmenteligible large vessel occlusion (LVO). Methods We systematically searched six databases up to July 2024 for studies conducted in Latin American countries reporting data on adult patients with AIS and confirmed LVO, or cohorts undergoing endovascular treatment for AIS-LVO. Because many studies enrolled AIS-LVO or treatment-selected populations, the primary analytic approach was descriptive synthesis. The main outcomes were 3-month mortality and favorable functional outcome at 3 months, defined as a modified Rankin Scale (mRS) score of 0–2. For outcomes with sufficiently harmonized denominators, exploratory random-effects meta-analyses of proportions were performed. Results A total of 16 studies were included, representing 3 countries: Brazil (n = 12), Argentina (n = 2), and Chile (n = 2). Favorable functional outcome at 3 months (mRS 0–2) was reported in 11 studies, corresponding to a crude descriptive proportion of 37.7% (938/2488). Mortality at 3 months was reported in 13 studies, corresponding to a crude descriptive proportion of 19.7% (498/2533). In exploratory random-effects meta-analyses, the pooled proportion of 3-month mortality was 21.0% (95% CI 16.9%–25.7%; I² = 73.0%), while the pooled proportion of favorable functional outcome was 37.3% (95% CI 21.6%–56.3%; I² = 91.4%). Sensitivity analyses excluding studies with fewer than 20 participants yielded similar mortality estimates but persistent high heterogeneity for favorable functional outcome. Conclusions Among published Latin American AIS-LVO cohorts, approximately one in five patients died by 3 months, whereas functional independence was achieved in a smaller and substantially more heterogeneous proportion of patients. These findings should be interpreted cautiously given the variability in study design, patient selection, denominator definitions, and outcome reporting across studies.
- 1 June 2026
- Published by Hospital Vozandes Quito - HVQ SA in Revista Medica Vozandes
- Vol. 36 (2) , 29
CLINICAL CHARACTERISTICS AND OUTCOMES OF LATIN AMERICAN PATIENTS WITH ACUTE ISCHEMIC STROKE AND LARGE VESSEL OCCLUSION: A SYSTEMATIC REVIEW AND EXPLORATORY META-ANALYSIS
Background Large vessel occlusion is a major cause of stroke-related disability and death and often requires access to specialized reperfusion strategies such as mechanical thrombectomy. However, published data from Latin America remain limited and methodologically heterogeneous. This study aimed to summarize the available evidence on the characteristics, management patterns, and clinical outcomes of Latin American cohorts of patients with acute ischemic stroke (AIS) and confirmed or treatmenteligible large vessel occlusion (LVO). Methods We systematically searched six databases up to July 2024 for studies conducted in Latin American countries reporting data on adult patients with AIS and confirmed LVO, or cohorts undergoing endovascular treatment for AIS-LVO. Because many studies enrolled AIS-LVO or treatment-selected populations, the primary analytic approach was descriptive synthesis. The main outcomes were 3-month mortality and favorable functional outcome at 3 months, defined as a modified Rankin Scale (mRS) score of 0–2. For outcomes with sufficiently harmonized denominators, exploratory random-effects meta-analyses of proportions were performed. Results A total of 16 studies were included, representing 3 countries: Brazil (n = 12), Argentina (n = 2), and Chile (n = 2). Favorable functional outcome at 3 months (mRS 0–2) was reported in 11 studies, corresponding to a crude descriptive proportion of 37.7% (938/2488). Mortality at 3 months was reported in 13 studies, corresponding to a crude descriptive proportion of 19.7% (498/2533). In exploratory random-effects meta-analyses, the pooled proportion of 3-month mortality was 21.0% (95% CI 16.9%–25.7%; I² = 73.0%), while the pooled proportion of favorable functional outcome was 37.3% (95% CI 21.6%–56.3%; I² = 91.4%). Sensitivity analyses excluding studies with fewer than 20 participants yielded similar mortality estimates but persistent high heterogeneity for favorable functional outcome. Conclusions Among published Latin American AIS-LVO cohorts, approximately one in five patients died by 3 months, whereas functional independence was achieved in a smaller and substantially more heterogeneous proportion of patients. These findings should be interpreted cautiously given the variability in study design, patient selection, denominator definitions, and outcome reporting across studies.
- Open Access
- 31 July 2024
- Published by Instituto Nacional Del Nino - San Borja in Investigación e Innovación Clínica y Quirúrgica Pediátrica
- Vol. 2 (2)
Linfangioma cervical gigante en paciente pediátrico: un reporte de caso
Los linfangiomas son alteraciones congénitas benignas poco frecuentes del sistema linfático. Su tamaño es variable, pudiendo causar síntomas compresivos y poner en riesgo la vida del paciente. La cirugíaes considerada la mejor opción terapéutica. Presentamos el caso de un paciente de un año de edad procedente de Pucallpa, Perú, que ingresó al Hospital Amazónico por presentar masa cervical derecha deformante compatible con un linfangioma quístico, con presencia de necrosis local. El paciente cursó con disfagia, llanto espontáneo, dolor, hiporexia, tos y fiebre. Se realizó una cirugía abierta con escisión completa de la masa y preservación de los componentes nerviosos y vasculares. La masa se caracterizó como un linfangioma según los hallazgos patológicos. El paciente evolucionó de manera favorable siendo dado de alta 8 días después de la cirugía. No se observaron complicaciones durante el año de seguimiento. En el caso presentado, el análisis patológico de la masa permitió establecer el diagnóstico de linfangioma; mientras que la cirugía abierta permitió extirpar el tumor sin mayores complicaciones. Se espera que la experiencia clínica presentada sea útil para el manejo efectivo de casos pediátricos de linfangioma con presentación similar.
- 31 July 2024
- Published by Instituto Nacional Del Nino - San Borja in Investigación e Innovación Clínica y Quirúrgica Pediátrica
- Vol. 2 (2)
Open AccessLinfangioma cervical gigante en paciente pediátrico: un reporte de caso
Los linfangiomas son alteraciones congénitas benignas poco frecuentes del sistema linfático. Su tamaño es variable, pudiendo causar síntomas compresivos y poner en riesgo la vida del paciente. La cirugíaes considerada la mejor opción terapéutica. Presentamos el caso de un paciente de un año de edad procedente de Pucallpa, Perú, que ingresó al Hospital Amazónico por presentar masa cervical derecha deformante compatible con un linfangioma quístico, con presencia de necrosis local. El paciente cursó con disfagia, llanto espontáneo, dolor, hiporexia, tos y fiebre. Se realizó una cirugía abierta con escisión completa de la masa y preservación de los componentes nerviosos y vasculares. La masa se caracterizó como un linfangioma según los hallazgos patológicos. El paciente evolucionó de manera favorable siendo dado de alta 8 días después de la cirugía. No se observaron complicaciones durante el año de seguimiento. En el caso presentado, el análisis patológico de la masa permitió establecer el diagnóstico de linfangioma; mientras que la cirugía abierta permitió extirpar el tumor sin mayores complicaciones. Se espera que la experiencia clínica presentada sea útil para el manejo efectivo de casos pediátricos de linfangioma con presentación similar.